CHEK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.986750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.505800E-01
Normal-vs-Stage2
1.906970E-01
Normal-vs-Stage3
6.338800E-01
Normal-vs-Stage4
3.270000E-01
Stage1-vs-Stage2
4.437400E-01
Stage1-vs-Stage3
4.438400E-01
Stage1-vs-Stage4
8.996400E-01
Stage2-vs-Stage3
2.461800E-01
Stage2-vs-Stage4
5.992400E-01
Stage3-vs-Stage4
4.797200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.025400E-01
Normal-vs-AfricanAmerican
2.655000E-01
Normal-vs-Asian
2.253400E-01
Caucasian-vs-AfricanAmerican
6.809000E-01
Caucasian-vs-Asian
4.216600E-01
AfricanAmerican-vs-Asian
8.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.417000E-01
Normal-vs-Female
1.661400E-01
Male-vs-Female
3.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.829600E-01
Normal-vs-Age(41-60Yrs)
1.771450E-01
Normal-vs-Age(61-80Yrs)
2.255200E-01
Normal-vs-Age(81-100Yrs)
1.826580E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.402800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.705200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.216800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.469350E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.430800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.829800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.768600E-01
Normal-vs-Daily Drinker
2.350600E-01
Normal-vs-Weekly Drinker
2.623400E-01
Normal-vs-Occasional Drinker
2.053400E-01
Normal-vs-Social Drinker
2.584600E-01
Non Drinker-vs-Daily Drinker
7.003400E-01
Non Drinker-vs-Weekly Drinker
5.379000E-01
Non Drinker-vs-Occasional Drinker
7.075600E-01
Non Drinker-vs-Social Drinker
7.258800E-01
Daily Drinker-vs-Weekly Drinker
7.839400E-01
Daily Drinker-vs-Occasional Drinker
9.997400E-01
Daily Drinker-vs-Social Drinker
9.917000E-01
Weekly Drinker-vs-Occasional Drinker
7.872600E-01
Weekly Drinker-vs-Social Drinker
8.141400E-01
Occasional Drinker-vs-Social Drinker
9.920000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.279000E-01
Normal-vs-Grade 2
7.044800E-01
Normal-vs-Grade 3
8.231000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.544700E-03
Grade 1-vs-Grade 3
4.37529999997022E-06
Grade 1-vs-Grade 4
6.279000E-01
Grade 2-vs-Grade 3
6.419100E-03
Grade 2-vs-Grade 4
7.044800E-01
Grade 3-vs-Grade 4
8.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.352200E-01
Normal-vs-NonDiabetic
1.820960E-01
Diabetic-vs-NonDiabetic
5.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.061600E-02
Normal-vs-NoPancreatitis
2.459200E-01
Pancreatitis-vs-NoPancreatitis
2.049800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.719450E-01
Normal-vs-N1
1.972400E-01
N0-vs-N1
6.878200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.909600E-02
Normal-vs-TP53-NonMutant
1.522160E-01
TP53-Mutant-vs-TP53-NonMutant
2.05189999991084E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
